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The FASEB Summer Research Conference on Microbial Pathogenesis: Mechanisms of Infectious
Disease was held in Colorado, USA in July 2007. The central theme was the interplay between path-
ogenic microbes and their mammalian hosts. Here, we review the presented research that highlights
this theme, including studies of both short-term and long-term interactions between microbes and
their hosts.Introduction
The mountain splendor of Snowmass, Colorado provided
a perfect setting for the 2007 FASEB Summer Research
Conference on Microbial Pathogenesis: Mechanisms of
Infectious Disease. This meeting, chaired by Brad Cook-
son (University of Washington, USA) and cochaired by Mi-
chele Swanson (University of Michigan, USA), brought to-
gether a diverse group of immunologists, bacteriologists,
virologists, parasitologists, and mycologists in an atmo-
sphere conducive to open discussion and idea exchange.
The central theme of the meeting was the interplay be-
tween pathogenic microbes and their mammalian hosts.
Appropriate for the theme, the Bernard Fields Keynote
Lecture was given by Nobel Laureate Peter Doherty (Uni-
versity ofMelbourne, Australia). Dr. Doherty enchanted the
audience by recounting his years spent investigating the
regulation of infection by T cells. He discussed his long-
standing interest in the factors that influence the quality
and quantity of CD8+ T cell responses to infection and
vaccination. His talk was peppered with entertaining per-
sonal tales about his experience in science, and he as-
sured young researchers that anyone with a ‘‘fire in their
belly’’ could become a Nobel Laureate.
The Initial Interaction between Microbes
and Their Hosts
Just over a decade ago, the late Charles Janeway led a re-
newed interest in the importance of innate immunity as the
first and critical line of defense against infectious agents.
Janeway proposed that the innate immune system, al-
though more limited in scope and unable to be fine-tuned
for precise specificity like the adaptive immune system,
recognizes specific (but common) pathogen-associated
molecular patterns (PAMPs) using individual pathogen-
recognition receptors (PRRs). The discovery of Toll as a
PRR in Drosophila was followed quickly by the identifica-
tion in mammals of extracellular Toll-like receptors (TLRs)
and intracellular Nod-like receptors (NLRs) (see Sanso-
netti [2006] for a recent review on this topic). While en-214 Cell Host & Microbe 2, October 2007 ª2007 Elsevier Inc.gagement of these receptors leads to activation of NF-kB
and the induction of proinflammatory cytokine gene ex-
pression, stimulation can also lead to cell death via the ac-
tivation of caspase-1 and formation of ‘‘inflammasomes.’’
Several talks at this meeting focused on understanding
various aspects of innate response to infection and the
interactions of pathogens with immune cells (Figure 1).
As part of its pathogenic strategy, the Gram-negative
bacterium Francisella tularensis enters and grows in the
cytosol of host cells, including macrophages (Henry and
Monack, 2007). Denise Monack (Stanford University,
USA) showed that F. tularensis activates an ASC adaptor-
containing inflammasome in bonemarrow-derivedmacro-
phages leading to pyroptosis (a cell death pathway that is
proinflammatory and uniquely dependent on caspase-1).
However, using amicroarray approach, her group showed
that a type I interferon (IFN) response was also induced by
Francisella and that the IFN response was required for the
activation of the inflammasome. These results suggest a
potentially global role for IFN-b as a positive activator of
the inflammasome, revealing a previously unappreciated
connection between these host response pathways. An-
other Gram-negative bacterium, Legionella pneumophila,
grows within a specialized vacuole of macrophages that
forms in response to proteins secreted by Legionella’s
Type 4 Secretion System (T4SS) (Nagai and Roy, 2003).
Craig Roy (Yale University, USA) showed that macro-
phages use TLR-2 to sense extracellular L. pneumophila,
resulting in the induction of IFN-g, and Nod1 and Nod2 to
detect intracellular bacterial components, leading to the
production of proinflammatory cytokines. Using MyD88-
and RIP2-deficient mice and T4SS-deficient bacteria, his
group also showed that additional receptors must be in-
volved in sensing L. pneumophila, and together, their
data suggest that, by integrating signals received through
multiple receptors, host cells are able to evaluate the loca-
tion, composition, and pathogenic strategy of invadingmi-
crobes. That host cells integrate signals from multiple
pathogen-sensing receptors was also evident from work
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hill (Cedars Sinai/UCLA, USA). Dectin-1 is a non-TLR
receptor that recognizes b-glucan, a component of the
cell wall of the yeast form ofCandida albicans and the my-
celial form of Aspergillus fumigatus (Dennehy and Brown,
2007). Engagement of Dectin-1 stimulates phagocytosis
of the fungi. Dr. Underhill showed that in addition to en-
hancing signaling through TLR-2, Dectin-1 induces signal-
ing through the Src/Syk and Nuclear Factor of Activated T
cells (NFAT) pathways, which are generally associated
with adaptive immune responses. As one example of how
microbes have learned to avoid innate host defenses, Wil-
liam Goldman (Washington University-St. Louis, USA)
showed that the dimorphic fungal pathogen Histoplasma
capsulatum covers the b-glucan on its surfacewith a-(1,3)-
glucan when it switches to the pathogenic yeast form,
thereby avoiding detection by Dectin-1 and subsequent
phagocytosis.
Yersinia spp. are Gram-negative bacteria that induce
apoptosis in naive macrophages in a manner dependent
on TLR-4 and YopJ, an effector secreted by Yersinia’s
Type 3 Secretion System (T3SS) (Bliska, 2006). Tessa
Bergsbaken (University of Washington, USA) showed,
however, that when macrophages were activated with
LPS or lipopeptide, Y. pseudotuberculosis induced pyrop-
tosis instead of apoptosis. Induction of pyroptosis re-
quired a functional T3SS but none of the known T3SS-de-
pendent effectors, suggesting that either an unidentified
effector or T3SS-dependent membrane perturbations
were responsible for activating the inflammasome. These
data suggest that Yersinia may induce apoptosis early in
Figure 1. Themes in Pathogen Interactions with Immune
Cellsinfection and then pyroptosis later, after activated macro-
phages have been recruited to the site of infection. This
hypothesis was supported by data presented by Peter
Dube (University of Texas Health Sciences Center, USA)
and Wyndham Lathem (Washington University-St. Louis,
USA) who have independently been studying the early
phases of pneumonic plague using Y. pestis and a mouse
model. Dr. Dube showed that inflammation was sup-
pressed during the first 24–36 hr of infection, coincident
with the induction of IL-10, but then increased rapidly as
IL-10 was replaced with proinflammatory cytokines MIP-
2 and keratinocyte chemoattractant (KC) in lung tissues.
Dr. Lathem showed that increased expression of plasmin-
ogen activator protease (Pla) by Y. pestis correlated with
the transition from the quiescent phase to the proinflam-
matory phase, although its role in the transition is currently
unknown. While the molecular mechanisms are not yet
understood, these data together indicate that both the
pathogen and the host make important contributions to
controlling the initial inflammatory response and the sub-
sequent course of the infection.
Whether viruses induce pyroptosis is unknown, but vi-
ral-induced cell death is apparent. Stacey Schultz-Cherry
(University of Wisconsin, USA) discussed the role of cell
death in influenza pathogenesis. Two cellular pathways
identified as involved in influenza virus-induced apoptosis
were regulated during influenza infection. Downregulating
both cellular pathways led tomore severe disease and en-
hanced inflammation, suggesting that host cell apoptosis
may be an important means of regulating the inflammatory
response.
Jayne Raper (New York University, USA) described a
completely different innate immune defense mechanism
that kills trypanosomes growing in the bloodstream. A
subfraction of high-density lipoprotein in the blood of hu-
mans and a few primates, called trypanosome lytic factor
(TLF), is endocytosed by certain trypanosomes and is
activated within the acidic lysosome, forming membrane
pores that kill the parasite (Raper et al., 2001). Dr. Raper’s
group generated transgenic mice expressing human TLF
and showed that, in addition to being less sensitive to the
trypanosomatid Leishmania major, these mice were also
less sensitive toSalmonella typhimurium, aGram-negative
bacterium that survives within macrophage phagosomes.
These results suggest that TLF is a broad-spectrum anti-
microbial component of the human innate immunesystem.
Secretory immunoglobulin (sIg) is a polyspecific, low-
affinity antibody that protects mucosal surfaces (Wijburg
et al., 2006). The polymeric immunoglobulin receptor
(pIgR) is responsible for the transit of sIg through the
epithelium. Richard Strugnell (University of Melbourne,
Australia) reported that mice lacking pIgR are more sus-
ceptible to low doses of orally inoculated Salmonella
typhimurium and more readily spread the organism to
other mice. Disturbances in the intestinal tract of the pIgR
mouse suggest that sIg participates in removal of antigen
from the subepithelial spaces.
The use of inbred ‘‘wild-type’’ and transgenic mice
raised in pathogen-free environments has greatlyCell Host & Microbe 2, October 2007 ª2007 Elsevier Inc. 215
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ing microbe-host interactions. However, in nature, hosts
are neither genetically homogeneous nor free of current
or past exposure to other pathogens. Janis Weis (Univer-
sity of Utah, USA) showed that C3H mice develop joint in-
flammation near the site of intradermal inoculation with
Borrelia burgdorferi, the agent of Lyme disease in humans,
and that infected tissue revealed strong upregulation of in-
terferon response genes (IRG). In contrast, C57BL/6 mice,
which develop only mild disease, showed decreased ex-
pression of IRG and instead activated an epidermal differ-
entiation/wound repair response. Although their inflamma-
tory responses and the severity of disease differed, both
strains of mice activated an effective bacterial clearance
response involving NF-kB signaling. These results serve
as an excellent reminder that data obtained using one
strain of mouse may not translate directly to others,
much less to other mammals, and therefore extrapolating
conclusions to human infection should be done with
caution.
Manuela Raffatellu (University of California-Davis, USA)
showed that the ability ofS. typhimurium to disseminate to
mesenteric lymph nodes following inoculation of ligated il-
eal loops was greatly increased in SIV-infected Rhesus
macaques compared to uninfected animals. SIV-infected
animals displayed a blunted cytokine response to Salmo-
nella, consistent with SIV-dependent depletion of gut Th17
cells. These observations demonstrate how infection by
one pathogen can alter the host immune response to
infection with another.
While it is apparent that manymicrobes participate in an
intimate two-way communication with host cells, some
simply deliver potent toxins capable of quickly killing host
cells. Erik Hewlett (University of Virginia, USA) presented
evidence that the adenylate cyclase toxins (ACT) pro-
duced by Bordetella pertussis and Bacillus anthracis kill
macrophages by both apoptotic and nonapoptotic path-
ways. Although the exact mechanisms are not yet under-
stood, cAMP accumulation, ATP depletion, and pore
formation all appear to be involved. Using a yeast model,
Dara Frank (Medical College of Wisconsin, USA) showed
that ExoU, an effector secreted by the Pseudomonas
aeruginosa T3SS, functions as an A2 phospholipase in
eukaryotic cells inducing necrotic cell death. Intriguingly,
ExoU only had phospholipase activity in the presence of
a host cell factor, which was shown to be superoxide dis-
mutase (SOD1). ExoU and SOD1 interact, and the dismu-
tase activity of SOD1 was not required for ExoU phospho-
lipase activity. Thus, not only does P. aeruginosa kill host
cells, it uses a host cell protein as a cofactor to do so. Us-
ing C. elegans as a model, Daniel Kalman (Emory Univer-
sity, USA) discovered that enteropathogenic Escherichia
coli (EPEC) produces a small molecule that paralyzes
and ultimately kills the nematodes. In addition, worms
exposed briefly to EPEC, were ‘‘conditioned’’ (or ‘‘immu-
nized’’) and survived a subsequent lethal exposure. This
conditioning required expression of dopaminergic neuro-
transmitters and the FOX-O family transcription factor,
DAF-16, which regulates expression of genes encoding216 Cell Host & Microbe 2, October 2007 ª2007 Elsevier Inc.protective factors. These signaling pathways are highly
conserved across species and their role in mammalian
systems is being pursued.
Secondary Interactions: Adaptive
Immunity Kicks In
Theadaptive immunesystem is critical for controllingpath-
ogens that are able to overcome innate responses and for
eliminating these same pathogens quickly upon subse-
quent exposure. The mounting of a secondary response
that is faster and more robust than the first requires the
development of memory T cells. John Harty (University of
Iowa, USA), by studying the biology of CD8+ T cell-medi-
ated immunity to the bacterium Listeria monocytogenes,
has demonstrated that it takes 40 days for a significant
population of memory T cells to develop. This time could
be shortened, however, if dendritic cells coated with Liste-
riapeptideswere administered at the time of primary infec-
tion or vaccination. These elegant studies demonstrated
that the rate at which CD8+ T cells acquire memory de-
pends on the degree of inflammation and can be
manipulated to improve the efficacy of prime and boost
vaccination.
Given the importance of T cell-mediated control of viral
infection, it is surprising how little is known about themod-
ulation of T cell function by viruses, especially herpesvi-
ruses. Ann Hill (Oregon Health & Science University,
USA) demonstrated that cells infected with cytomegalovi-
ruses (CMV) are destroyed by CD8+ T cells if they express
a high enough level of MHC-I, but that a long interaction
time is required. Noncognate MHC-I-peptide complexes
played an important role in facilitating lysis. Not surpris-
ingly, CMV encode multiple genes that inhibit the ability
of cytotoxic T lymphocytes to lyse infected targets. An-
drew Evans (Emory University, USA) demonstrated that
a murine gammaherpesvirus encodes a secreted protein
that stimulates T cells expressing Vb4+ receptors specifi-
cally, reminiscent of the effects of other viral or bacterial
superantigens. This unique T cell response appears to
limit viral reactivation among specific cell types via IFN-g,
thus promoting viral latency in a manner independent of
the antigen-specific immune response. Such T cell modu-
lation is not without negative consequences, however, as
this viral protein appears to mediate immunopathology in
certain knockout strains of mice.
Hepatitis C virus (HCV) is persistent and prevalent, af-
fecting over 3% of the world population, and notoriously
difficult to study. Using lymphocytes from blood and liver
of HCV-infected patients, Kyong-Mi Chang (University of
Pennsylvania and Philadelphia VA, USA) examined regula-
tory and effector T cells in HCV-infected patients. Her
work provided evidence that virus-specific T cells, but not
B cells, are associated with viral clearance during acute
infection. Further, numerous immune regulatory mecha-
nisms were apparently activated in HCV-infected patients
and a hierarchy in antiviral CD8+ T cells was observed.
CD8+ T cell responses are generally not associated with
extracellular pathogens but exciting work by Molly Berg-
man (Tufts University, USA) demonstrated that CD8+ T
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sis. Moreover, the host protein perforin, which is involved
in cytotoxic T cell-mediated lysis of infected cells, was
also required to limit bacterial growth. These results sug-
gest that immune mechanisms that typically target intra-
cellular pathogens also function to eliminate extracellular
pathogens.
The ability of microbes to change their surface proper-
ties to avoid recognition and clearance by the adaptive
immune response, called antigenic variation, has been
known for many years, and in some cases the underlying
genetic mechanisms are understood (van der Woude and
Baumler, 2004). Investigating the mechanism of antigenic
variation in Treponema pallidum, the causal agent of syph-
ilis, has been challenging, but Sheila Lukehart (University
of Washington, USA) has discovered that a T. pallidum
surface protein called TprK, a target of opsonic anti-
bodies, undergoes phase variation in response to immune
pressure, and that the underlying mechanism involves
segmental gene conversion from adjacent chromosomal
variable region cassettes. Another form of phase variation
occurs when erythrocytes infected with the malaria
parasite Plasmodium express one of60 polymorphic cy-
toadherence genes encoding PfEMP1 on the infected cell
surface. Switching between PfEMP1 genes precludes an-
tibody neutralization. Kirk Dietsch (Cornell University,
USA) reported that exclusive expression of one PfEMP1
gene from its upstream promoter is dictated by a silencing
mechanism involving intron-dependent expression of a
noncoding, ‘‘sterile’’ RNA from each PfEMP1 gene. Both
silencing and recognition for mutually exclusive expres-
sion depend on the upstream promoter and intron pro-
moter being in a one-to-one ratio, suggesting that interac-
tions between the two are required for proper epigenetic
regulation. Although flagellar phase variation inSalmonella
species is generally well understood, Stephen Baker
(Wellcome Trust Sanger Institute, UK) described two novel
flagella variants that exist in Salmonella strains isolated
from Indonesia. In one type, genes resembling the regula-
tors of phase variation in other Salmonella subspecies are
located on a linear plasmid. Differences in flagella type
correlated with differences in invasiveness of the organ-
isms for cultured cells.
Long-Term Interactions: Commensalism,
Chronic Infection, Latency
In some instances, the responses of the host to the pres-
ence of an invader are balanced by the strategies used
by the organism to resist clearance, and the result is
a standoff in which the microbe persists within the host
in the absence of overt disease. This microbial coloniza-
tion may represent a commensal relationship in which the
organism is considered a component of the normal flora.
An example is colonization of the avian intestinal tract by
the enteric bacterium Campylobacter jejuni. As described
by Victor DiRita (University of Michigan, USA), coloniza-
tion requires C. jejuni genes involved in flagellar motility,
nutrient acquisition, and surprisingly, protein N-glycosyl-
ation (Hendrixson and DiRita, 2004). Although uncommonin most bacteria, over 30 C. jejuni proteins are N-glycosy-
lated. A putative zinc-binding, N-glycosylated periplas-
mic protein that may be involved in zinc acquisition is
needed for normal colonization. Some of the glycopro-
teins are also required for invasion of a human intestinal
epithelial cell line, suggesting that determinants of coloni-
zation in the chicken also promote disease when the
organism is ingested by an ‘‘accidental’’ host such as
a human.
The opportunistic fungal pathogen Candida albicans
has a complex relationship with its human host, colonizing
as a commensal but capable of becoming an invasive
pathogen if the host becomes immunocompromised.
C.A.K. (Tufts University, USA) described a gene encoding
a putative transcription factor that is expressed by fungal
cells colonizing the intestinal tract of mice in the absence
of disease. Genetic manipulation of this gene resulted in
changes in intestinal colonization, but the gene was not
required for lethality following intravenous inoculation of
C. albicans. The converse situation, genes required for
normal lethality in the intravenous model but not for intes-
tinal colonization, was also described. These results sug-
gest that, for C. albicans, the commensal state is distinct
from the pathogenic state, and each has a characteristic
genetic program.
Other pathogens utilize specializedmechanisms that al-
low them to persist for long periods of time within the host.
Mycobacterium tuberculosis, for example, can remain
dormant within macrophages, with reactivation resulting
in disease many years after the primary exposure. Clifford
Harding (Case Western Reserve University, USA) pre-
sented evidence that M. tuberculosis actively inhibits ex-
pression of class II MHC on macrophages (Pecora et al.,
2006) by decreasing the expression of CIITA, a transcrip-
tional activator required for sustained expression of MHC-
II. This strategy promotes persistence in these cells while
avoiding detection by CD4+ T cells. Correlia Detweiler
(University of Colorado, USA) described a mechanism
used for long-term persistence by Salmonella typhimu-
rium, an organism associated with persistent infection of
carriers. In a murine host, persisting organisms were de-
tectedwithinmacrophages that containedother cell types,
including neutrophils and T cells. In laboratory experi-
ments, bacteria were shown to survive and replicate within
activated bone marrow-derived macrophages that had
ingested other live, but not dead, cells such as T cells. In-
triguingly, ‘‘hemophagocytosis’’ (defined as the engulf-
ment of erythrocytes, leukocytes, platelets, and precursor
cells by activated macrophages) has been described in
humans suffering from typhoid fever and may aid the
survival of Salmonella.
An extreme example of a standoff is viral latency. In this
situation, the virus exists in a latent state for long periods
of time, potentially for the life span of the host, and re-
mains capable of reactivating to produce active disease.
Although latent infection represents a quiescent stage in
the viral life cycle, Michael Lagunoff (University of Wash-
ington, USA) reported that latent infection with Kaposi’s
sarcoma-associated herpesvirus (KSHV) converts bloodCell Host & Microbe 2, October 2007 ª2007 Elsevier Inc. 217
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et al., 2004) in part by upregulating the lymphangiogenic
marker Vascular Endothelial Growth Factor Receptor 3
(VEGF R3) via activation of STAT3 signaling. In addition,
activation of the hypoxia transcription factors HIF1a and
HIF2a triggers expression of the angiogenic receptor
VEGF R1. Activation of these angiogenic and lymphangio-
genic pathwaysmay contribute to the prominent vascular-
ization of Kaposi’s sarcomas.
Special Topics
Environmental Sensing: How Do the Pathogens
Know Where They Are?
Pathogens must be proficient at sensing their surround-
ings and responding to cues that promote survival in the
face of a changing environment. Dimorphic (‘‘two-phase’’)
pathogenic fungi (e.g., Blastomyces dermatitidis and His-
toplasma capsulatum) sense an increase in temperature to
undergo a dramatic phase transition from a mycelial form
in soil to a yeast form in the human lung. Bruce Klein (Uni-
versity of Wisconsin, USA) described how this transition is
critically dependent on a phosphorelay-type signaling
system in which the hybrid sensor Drk1 (dimorphism reg-
ulating kinase 1) phosphorylates a response regulator
(similar to Ssk1 in S. cerevisiae), ultimately driving expres-
sion of yeast-specific virulence factors such as the B. der-
matitidis adhesin Bad1 (Nemecek et al., 2006).
Rachel Edwards (University of Michigan, USA) de-
scribed how Legionella pneumophila uses a ppGpp syn-
thase called SpoT to monitor fatty acid (FA) metabolism.
Perturbation of FAmetabolism cues replicative cells to dif-
ferentiate to a growth-arrested, motile, infectious form
equipped for transmission from one host cell to another.
Inhibitors that selectively block initiation or elongation of
FA trigger phase transition in a SpoT-dependent manner,
as do short-chain FA such as acetic acid or proprionic
acid. Although it seems likely that SpoT senses perturba-
tions in FA biosynthesis through its known interaction with
acyl carrier protein, precisely how it does this and which
genes respond to elevation of ppGpp remain active areas
of investigation.
Enterohemorrhagic E. coli (EHEC) also uses a sophisti-
cated surveillance system to taste cues from its host and
the surrounding gut microflora. Vanessa Sperandio (Uni-
versity of Texas-Southwestern, USA) showed that EHEC
senses increasing host epinephrine (ep) and norepineph-
rine (norep) levels to activate virulence gene expression.
It also monitors levels of autoinducer-3 (AI-3) produced
by itself and other gutmicroflora to express virulence traits
such as attachment and effacement. Although ep/norep
and AI-3 appear to recognize the same bacterial receptor,
downstream signaling occurs through distinct multicom-
ponent phosphotransfer systems regulating the expres-
sion kinetics of these traits (Reading et al., 2007; Russell
et al., 2007; Sharp and Sperandio, 2007). It is proposed
that signaling to initiate flagellum-based movement to
the gut epithelium occurs before signaling that activates
attachment and effacement. A small-molecule antagonist
(LED209) of AI-3 signaling identified in a high-throughput218 Cell Host & Microbe 2, October 2007 ª2007 Elsevier Inc.screen blocks EHEC effacement and also inhibits macro-
phage infection with Francisella tularensis, raising the ex-
citing prospect of selectively downregulating virulence
as a treatment strategy.
Manipulating Host Cell Functions
to Get In and Move Around
Intracellular pathogens are adept at subverting host cell
processes to their advantage. Brucella abortus is an intra-
cellular bacterium that replicates within a vacuole whose
membrane is derived from the endoplasmic reticulum.
Jean Celli (NIAID, USA) showed that, prior to residing
within amature ER-derived vacuole that is capable of sup-
porting Brucella replication, the organism resides in an in-
termediate vacuole that acquires lysosomal markers and
intersects with the endocytic system. Maturation of the
intermediate vacuole to the mature vacuole requires acid-
ification and is Rab7 dependent.
Isabelle Coppens (Johns Hopkins University, USA)
showed that the intracellular protozoan Toxoplasma gon-
dii becomes encased in a network of host microtubules
and lysosomes, some of which can be seen encroaching
within the parasitophorous vacuole (PV) but still sur-
rounded by the PV membrane (Coppens et al., 2006). It
is proposed that cholesterol and other nutrients are trans-
ferred from the encroaching lysosomes into the PV where
they can be consumed by the parasite. In this manner the
parasite selectively obtains essential nutrients without
risking exposure to hydrolytic enzymes of the host. Toxo-
plasma is highly adept at crossing biological barriers such
as the blood brain barrier or the placenta during dissemi-
nation and transmission. To understand the mechanism
that allows the organisms to breach these barriers, Dr. An-
tonio Barragan (Karolinska Institute, Sweden) analyzed
the motility of the parasite and of infected host cells. Re-
sults showed that intracellular parasites stimulated hyper-
motility in dendritic cells (DC) and other cells (Lambert
et al., 2006). In mice inoculated with Toxoplasma-ladened
DC, faster dissemination and more severe infection were
observed in comparison to mice inoculated with the or-
ganism alone. These results suggest that Toxoplasma
uses DC and other migratory immune cells as a ‘‘Trojan
horse’’ to slip through biological barriers to access privi-
leged tissues and organs.
Discovery of New Virulence Factors
Like many parasites, Plasmodium, the agent of malaria,
has a complex life cycle. Consequently, a large fraction
of Plasmodium genes are of unknown function. To gain in-
sight into their functions, Elizabeth Winzeler (Scripps Insti-
tute, USA) described approaches that utilize gene expres-
sion data generated from organisms grown under a wide
variety of conditions. By observing coexpression of genes
of unknown function with genes of known function,
Dr. Winzeler was able to generate and test hypotheses
for the function of many unknown genes.
Inspection of the genome sequence of the flea-trans-
mitted bacterium Yersinia pestis revealed the presence
of a cluster of genes with homology to insecticidal toxin-
encoding genes fromPhotorhabdus luminescens. Carleen
Collins (University of Washington, USA) showed that the
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are deployed by a T3SS, and together they have tyrosine
phosphatase activity. Flea infection experiments indicate
that these proteins may contribute to blockage of the
flea proventriculus, thereby facilitating transmission by
the flea vector.
Autotransporters (AT) are proteins that appear to medi-
ate their own export across the outermembranes ofGram-
negative bacteria (Henderson et al., 2004). Nearly all that
have been studied play roles in pathogenesis. The Y. pes-
tis genome contains 12 uncharacterized ORFs with the
potential to encode ATs. Matthew Lawrenz (Washington
University, USA) described evidence that these genes
(collectively called yaps) are expressed duringmammalian
infection by Y. pestis, and that several localize to the outer
membrane when expressed in E. coli. By constructing and
characterizing Y. pestis strains with in-frame deletion mu-
tations in these genes, he showed that at least four play
a role in the infection and that one, yapE, is important for
dissemination of Y. pestis from the lymph nodes to deeper
tissues such as the spleen and lungs.
New Vesicular Trafficking Pathways and Tools
David Haslam (Washington University, USA) described
using a luciferase reporter system in a high-throughput
screen to identify small molecules that inhibit the transport
of microbial toxins, such as Shiga toxin, inside eukaryotic
cells. The screen identified a compound, called B06, that
interferes with the budding of vesicles from the Golgi and
TGN. B06 appears to do this by inhibiting the polymeriza-
tion of Arf1-coat complexes into an oligomeric lattice. Be-
cause B06 affects a different step in vesicular transport
than Brefeldin A, it will be a useful tool for investigating
intracellular transport pathways, which are often exploited
by pathogenic microbes.
New Vaccination Strategies
Vaccination strategies often target healthy populations
and standard vaccines may not work in special popula-
tions such as neonates, the elderly, pregnant women, or
immunocompromised individuals. Marcela Pasetti (Uni-
versity of Maryland, USA) presented a new vaccination
strategy that exploits the properties of particles derived
from killed Lactococcus lactis organisms. These particles
elicit responses in dendritic cells from neonatal mice or
from human umbilical cord blood offering potential as a
means to develop vaccines for infants and neonates.
Conclusions
The host-pathogen interaction is an intricate ‘‘dance.’’
Sometimes the pathogen leads, and other times it is the
host that is in control. Ultimately, the interactions lead to
a resolution favoring one or the other or to a balanced sit-
uation in which the two coexist. This meeting emphasizedthe importance of the interactions and the ability of both
parties to respond to each other. What wasmost apparent
is that pathogens, regardless of the type, use similar
mechanisms to evade and control the host immune re-
sponse. The discussions at this meeting promoted the ap-
preciation that pathogens may differ in many ways, but
they are also similar. Through sharing of knowledge and
collaborations between investigators with diverse exper-
tise but a general focus on pathogenesis, we may one day
uncover the keys to preventing infectious diseases, pro-
tecting susceptible individuals, or improving therapeutic
interventions.
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